pilocarpine has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartenstein, P; Buchholz, HG; Cumming, P; Debus, F; Dupont, E; Fellgiebel, A; Heimann, A; Landvogt, C; Luhmann, HJ; Potschka, H; Schreckenberger, M; Tillmanns, J; Werhahn, KJ; Yakushev, IY | 1 |
1 other study(ies) available for pilocarpine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
| Article | Year |
|---|---|
In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.
Topics: Animals; Autoradiography; Benzamides; Brain; Brain Mapping; Corpus Striatum; Disease Models, Animal; Dopamine; Epilepsy, Temporal Lobe; Humans; Male; Pilocarpine; Positron-Emission Tomography; Pyrrolidines; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2010 |